{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:36:28Z","timestamp":1788986188678,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.ijantimicag.2008.12.005","type":"journal-article","created":{"date-parts":[[2009,2,9]],"date-time":"2009-02-09T09:13:07Z","timestamp":1234170787000},"page":"515-519","source":"Crossref","is-referenced-by-count":47,"title":["Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia"],"prefix":"10.1016","volume":"33","author":[{"given":"Ian","family":"Morrissey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Janes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2008.12.005_bib1","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.2165\/00003495-200767160-00005","article-title":"Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options","volume":"67","author":"Van Bambeke","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2008.12.005_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11908-007-0035-y","article-title":"Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia","volume":"9","author":"Stankovic","year":"2007","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ijantimicag.2008.12.005_bib3","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1128\/AAC.01563-06","article-title":"Increasing ceftriaxone resistance and multiple alterations of penicillin-binding proteins among penicillin-resistant Streptococcus pneumoniae isolates in Taiwan","volume":"51","author":"Chiu","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.005_bib4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1378\/chest.06-1994","article-title":"Recent advances in community-acquired pneumonia: inpatient and outpatient","volume":"131","author":"Niederman","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2008.12.005_bib5","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2008.12.005_bib6","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/AAC.49.8.3501-3512.2005","article-title":"Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains","volume":"49","author":"Sader","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.005_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jac\/dkm150","article-title":"In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes","volume":"60","author":"Mushtaq","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.005_bib8","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1128\/AAC.00149-08","article-title":"In vitro profiling of ceftaroline against a collection of recent bacterial isolates from across the United States","volume":"52","author":"Ge","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.005_bib9","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1128\/AAC.00590-07","article-title":"Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections","volume":"51","author":"Talbot","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.12.005_bib10","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 6th ed. M7-A7. Wayne, PA: CLSI; 2006."},{"key":"10.1016\/j.ijantimicag.2008.12.005_bib11","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. M100-S17. Wayne, PA: CLSI; 2007."},{"key":"10.1016\/j.ijantimicag.2008.12.005_bib12","unstructured":"Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline. M45-A. Wayne, PA: CLSI; 2006."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857909000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T00:52:52Z","timestamp":1545439972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857909000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0924857909000053"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.12.005","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}